XOMA Royalty (XOMA) Other Non-Current Assets (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Other Non-Current Assets came in at $44.3 million in Q1 2026, up 1221.03% year-on-year from $3.4 million in Q1 2025, and down 2.38% quarter-over-quarter from $45.4 million in Q4 2025.

XOMA Royalty (XOMA) Other Non-Current Assets (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Other Non-Current Assets across 17 years of filings, most recently posting $44.3 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $44.3 million, up 1221.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.3 million (up 1221.03% YoY), and the FY2025 annual result was $45.4 million, up 1221.71% from the prior year.
  • Other Non-Current Assets came in at $44.3 million for Q1 2026 at XOMA Royalty, down from $45.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $45.4 million in Q4 2025 to a low of $260000.0 in Q2 2022.
  • The 5-year median for Other Non-Current Assets is $3.3 million (2025), against an average of $9.5 million.
  • Across the five-year window, Other Non-Current Assets plunged 85.67% in 2022 and jumped 2246.15% in 2023, its largest moves.
  • XOMA Royalty's Other Non-Current Assets stood at $260000.0 in 2022, then surged by 2246.15% to $6.1 million in 2023, then plunged by 43.74% to $3.4 million in 2024, then soared by 1221.71% to $45.4 million in 2025, then fell by 2.38% to $44.3 million in 2026.
  • The last three Other Non-Current Assets figures came in at $44.3 million (Q1 2026), $45.4 million (Q4 2025), and $40.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 60,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.26 Bn
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - 44.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.28 Mn
Dec 31, 2025 45.36 Mn
Sep 30, 2025 40.08 Mn
Jun 30, 2025 3.35 Mn
Mar 31, 2025 3.35 Mn
Dec 31, 2024 3.43 Mn
Sep 30, 2024 1.93 Mn
Jun 30, 2024 6.02 Mn
Mar 31, 2024 6.02 Mn
Dec 31, 2023 6.10 Mn
Sep 30, 2023 411,000.00
Jun 30, 2023 283,000.00
Mar 31, 2023 260,000.00
Dec 31, 2022 260,000.00
Sep 30, 2022 260,000.00
Jun 30, 2022 260,000.00
Mar 31, 2022 301,000.00
Dec 31, 2021 301,000.00
Sep 30, 2021 301,000.00
Jun 30, 2021 128,000.00